Skip to main content

Table 1 Baseline characteristics of the patients

From: Novel myocardial markers GADD45G and NDUFS5 identified by RNA-sequencing predicts left ventricular reverse remodeling in advanced non-ischemic heart failure: a retrospective cohort study

variablesRR group
(n = 8)
non-RR group
(n = 9)
P value
Age46.1 ± 14.347.1 ± 9.40.87
Male Sex, n680.45
Disease duration (months)36.1 ± 65.579.0 ± 46.50.14
Height (cm)165 ± 9168 ± 50.35
Weight (kg)64.1 ± 12.567.2 ± 9.40.56
BMI23.4 ± 3.923.8 ± 3.20.83
HR (bpm)90 ± 2384 ± 200.63
Method of biopsy (transcatheter /surgery)4/40/90.019
Treatment
 Beta-blocker, n780.93
 ACEI or ARB, n680.45
 Inotropes, n280.008
 IABP, n020.16
 AVR, n210.45
 VAD implantation, n280.008
Labo data
 Hb (g/dL)12.8 ± 2.311.4 ± 1.70.17
 T-Bil (mg/dl)1.1 ± 0.31.2 ± 0.80.70
 Cre (mg/dl)0.92 ± 0.361.40 ± 0.450.029
 BNP (pg/ml)725 ± 454475 ± 1770.15
Echocardiogram
 LVDD (mm)72 ± 1079 ± 120.19
 LVDS (mm)65 ± 872 ± 120.20
 LVEF (%)21.5 ± 5.120.4 ± 4.20.63
 LAD (mm)50 ± 954 ± 110.43
 AR (moderate to severe, n)210.45
 MR (moderate to severe, n)660.71
 TR (moderate to severe, n)230.71
Hemodynamics
 PAP, mean (mmHg)36 ± 1038 ± 100.60
 PCWP, mean (mmHg)27 ± 629 ± 90.57
 RAP, mean (mmHg)10 ± 213 ± 60.16
 CO (L/min)4.02 ± 0.683.79 ± 0.900.56
 CI (L/min/m2)2.30 ± 0.342.06 ± 0.470.25
 PVR (Wood)2.41 ± 1.662.45 ± 1.610.96
  1. Data are shown as the mean value ± standard deviation, or number of the patients
  2. Abbreviations: BMI body mass index; HR heart rate; ACEI angiotensin converting enzyme inhibitor; ARB angiotensin II receptor blocker; IABP intraaortic balloon pumping; AVR aortic valve replacement; VAD ventricular assist device; Hb hemoglobin; T-Bil total bilirubin; Cre creatinine; LVDD left ventricular diastolic diameter; LVDS left ventricular systolic diameter; LVEF left ventricular ejection fraction; LAD left atrial diameter; AR aortic regurgitation; MR mitral regurgitation; TR tricuspid regurgitation; PAP pulmonary artery pressure; PCWP pulmonary capillary wedge pressure; RAP right atrial pressure; CO cardiac output; CI cardiac index; PVR pulmonary vascular resistance